INVMEDIUM SIGNALFINANCIAL10-K

INV shows revenue growth but concerning balance sheet contraction with stockholders' equity declining significantly and total assets falling substantially.

The company appears to be in a capital-intensive phase with meaningful revenue expansion but at the cost of balance sheet strength. The substantial reduction in stockholders' equity alongside asset contraction suggests either capital deployment challenges or potential restructuring activities that warrant investor scrutiny.

Comparing 2026-03-30 vs 2025-04-14View on EDGAR →
FINANCIAL ANALYSIS

INV demonstrated strong revenue growth with income roughly doubling year-over-year, indicating operational momentum in its industrial conglomerate model. However, the balance sheet tells a more concerning story with stockholders' equity declining by over half and total assets contracting by one-third, while inventory levels also fell significantly. This divergence between income statement growth and balance sheet contraction suggests the company may be managing through a capital-intensive transition period or facing working capital optimization challenges.

FINANCIAL STATEMENT CHANGES
Revenue
P&L
+84.1%
$1.1M$2.1M

Strong top-line growth of 84.1% — accelerating demand or successful expansion into new markets.

Inventory
Balance Sheet
-69%
$5.2M$1.6M

Inventory drawn down 69% — strong sell-through or deliberate destocking; watch for supply constraints.

Stockholders Equity
Balance Sheet
-52%
$425.5M$204.2M

Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.

Total Assets
Balance Sheet
-33.8%
$905.3M$599.2M

Total assets contracted 33.8% — asset sales, write-downs, or balance sheet optimization underway.

Total Liabilities
Balance Sheet
-16.9%
$139.0M$115.5M

Liabilities reduced 16.9% — deleveraging improves balance sheet strength and financial flexibility.

LANGUAGE CHANGES
NEW — 2026-03-30
PRIOR — 2025-04-14
ADDED
Solely for purposes of this disclosure, shares of common stock held by executive officers, directors, and beneficial holders of 10% or more of the outstanding common stock of the registrant as of such date have been excluded because such persons may be deemed to be affiliates As of March 23, 2026, the registrant had 80,069,319 shares of common stock outstanding.
Such Proxy Statement will be filed with the Securities and Exchange Commission within 120 days of the registrant s fiscal year ended December 31, 2025.
(together, the WTI Lenders ) under the WTI Facility (as defined below); Innventure s access to funds under the Standby Equity Purchase Agreement (the SEPA ) with YA II PN, Ltd.
Overview Innventure is an industrial growth conglomerate that founds, funds, and operates companies with a focus on commercializing transformative, sustainable technology solutions acquired or licensed from multinational corporations ( MNCs ) or other technology innovators (collectively, Technology Solutions Providers ) with the intent to maximize value for investors and other stakeholders through positive cash flow generated through long-term ownership of our Innventure Companies (as defined below).
These Technology Solutions Providers are typically MNCs but need not be MNCs.
+7 more — sign up free →
REMOVED
The registrant s common stock began regular-way trading on the Nasdaq Global Market on October 3, 2024.
As of April 8, 2025, the registrant had 47,106,300 shares of common stock outstanding.
Overview Innventure founds, funds, and operates companies with a focus on transformative, sustainable technology solutions that we acquire or license from technology innovators.
These technology innovators are typically MNCs but need not be MNCs.
( PureCycle or PCT ) in late 2015 (technology initially sourced from The Procter Gamble Company ( P G )), AeroFlexx, LLC ( AeroFlexx or AFX ) in 2018 (technology sourced from P G), and Accelsius Holdings LLC ( Accelsius or ACC ) in 2022 (technology initially sourced from the Nokia Corporation ( Nokia )), and Refinity Olefins, LLC ( Refinity ) in 2024 (technology initially sourced from the VTT Technical Research Centre of Finland ( VTT ); collaboration agreement with The Dow Chemical Company ( Dow ) signed).
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →